ArrowMark Colorado Holdings’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-26,020
Closed -$2.5M 355
2021
Q3
$2.5M Sell
26,020
-571,579
-96% -$54.8M 0.02% 277
2021
Q2
$58.2M Sell
597,599
-31,278
-5% -$3.04M 0.44% 71
2021
Q1
$61.2M Buy
628,877
+29,573
+5% +$2.88M 0.46% 65
2020
Q4
$57.4M Buy
599,304
+51,716
+9% +$4.96M 0.45% 70
2020
Q3
$52.7M Sell
547,588
-7,152
-1% -$688K 0.5% 60
2020
Q2
$67.7M Buy
554,740
+41,269
+8% +$5.03M 0.7% 49
2020
Q1
$44.4M Buy
513,471
+25,019
+5% +$2.17M 0.58% 59
2019
Q4
$52.5M Buy
488,452
+45,502
+10% +$4.89M 0.47% 68
2019
Q3
$39.9M Buy
442,950
+54,140
+14% +$4.88M 0.4% 69
2019
Q2
$32.8M Sell
388,810
-8,267
-2% -$698K 0.32% 87
2019
Q1
$35M Buy
397,077
+18,382
+5% +$1.62M 0.33% 88
2018
Q4
$27M Buy
378,695
+3,263
+0.9% +$233K 0.28% 98
2018
Q3
$46.2M Sell
375,432
-341,012
-48% -$41.9M 0.39% 86
2018
Q2
$70.4M Sell
716,444
-25,703
-3% -$2.53M 0.65% 59
2018
Q1
$61.5M Sell
742,147
-55,567
-7% -$4.61M 0.62% 60
2017
Q4
$61.9M Sell
797,714
-90,232
-10% -$7M 0.63% 58
2017
Q3
$54.4M Sell
887,946
-7,633
-0.9% -$468K 0.62% 55
2017
Q2
$41.2M Sell
895,579
-111,419
-11% -$5.13M 0.51% 70
2017
Q1
$43.6M Buy
1,006,998
+115,471
+13% +$5M 0.59% 60
2016
Q4
$34.5M Buy
891,527
+78,400
+10% +$3.03M 0.55% 60
2016
Q3
$41.2M Buy
813,127
+51,667
+7% +$2.62M 0.75% 45
2016
Q2
$34.6M Buy
761,460
+36,350
+5% +$1.65M 0.7% 48
2016
Q1
$28.7M Buy
725,110
+235,002
+48% +$9.29M 0.64% 55
2015
Q4
$27.7M Sell
490,108
-42,914
-8% -$2.43M 0.76% 42
2015
Q3
$21.2M Sell
533,022
-189,827
-26% -$7.55M 0.58% 57
2015
Q2
$34.5M Sell
722,849
-38,481
-5% -$1.84M 0.84% 41
2015
Q1
$30.2M Sell
761,330
-712,159
-48% -$28.3M 0.78% 46
2014
Q4
$32.9M Sell
1,473,489
-71,090
-5% -$1.59M 0.85% 36
2014
Q3
$24.2M Sell
1,544,579
-112,094
-7% -$1.76M 0.66% 51
2014
Q2
$24.6M Buy
1,656,673
+400,252
+32% +$5.94M 0.7% 51
2014
Q1
$20.2M Buy
1,256,421
+658,580
+110% +$10.6M 0.66% 54
2013
Q4
$5.58M Buy
597,841
+343,798
+135% +$3.21M 0.17% 144
2013
Q3
$2.88M Buy
254,043
+6,476
+3% +$73.3K 0.09% 163
2013
Q2
$3.31M Buy
+247,567
New +$3.31M 0.89% 31